Atsunobu Sagara

415 total citations
22 papers, 322 citations indexed

About

Atsunobu Sagara is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Atsunobu Sagara has authored 22 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Atsunobu Sagara's work include Lung Cancer Treatments and Mutations (3 papers), Allergic Rhinitis and Sensitization (2 papers) and Pharmacy and Medical Practices (2 papers). Atsunobu Sagara is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Allergic Rhinitis and Sensitization (2 papers) and Pharmacy and Medical Practices (2 papers). Atsunobu Sagara collaborates with scholars based in Japan. Atsunobu Sagara's co-authors include Minoru Narita, Hiroyasu Sakai, Ken Sato, Kenjiro Matsumoto, Syunji Horie, Motohiro Matoba, Ara Jo, Satoshi Hasegawa, Yoshihiko Chiba and Yoshinori Katō and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and European Journal of Pharmacology.

In The Last Decade

Atsunobu Sagara

17 papers receiving 317 citations

Peers

Atsunobu Sagara
Yang Zheng China
Lijun Yang China
Fengming Zhu China
Luca Pacini Italy
Benling Qi China
Xueran Kang China
Krishna C. Penumatsa United States
Yang Zheng China
Atsunobu Sagara
Citations per year, relative to Atsunobu Sagara Atsunobu Sagara (= 1×) peers Yang Zheng

Countries citing papers authored by Atsunobu Sagara

Since Specialization
Citations

This map shows the geographic impact of Atsunobu Sagara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsunobu Sagara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsunobu Sagara more than expected).

Fields of papers citing papers by Atsunobu Sagara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsunobu Sagara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsunobu Sagara. The network helps show where Atsunobu Sagara may publish in the future.

Co-authorship network of co-authors of Atsunobu Sagara

This figure shows the co-authorship network connecting the top 25 collaborators of Atsunobu Sagara. A scholar is included among the top collaborators of Atsunobu Sagara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsunobu Sagara. Atsunobu Sagara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abe, Tomoya, Atsunobu Sagara, Takayuki Suzuki, et al.. (2025). Safety study on switching from intravenous to fixed‑dose subcutaneous formulation of pertuzumab and trastuzumab. Molecular and Clinical Oncology. 22(3). 24–24.
2.
Sagara, Atsunobu, et al.. (2025). Cross-sectional survey on cancer patients’ concerns and consultation needs with pharmacists at the time of initial diagnosis. Journal of Pharmaceutical Health Care and Sciences. 11(1). 59–59.
3.
Abe, Tomoya, et al.. (2024). Evaluation of the Simple Suspension Method for Oral Anticancer Drugs. YAKUGAKU ZASSHI. 144(4). 441–445. 1 indexed citations
4.
Shimizu, Takatsune, Atsunobu Sagara, Yumi Fukuchi, & Akihiro Muto. (2024). Single‑agent nintedanib suppresses metastatic osteosarcoma growth by inhibiting tumor vascular formation. Oncology Letters. 27(3). 123–123. 2 indexed citations
5.
Suzuki, Shinya, Atsunobu Sagara, Tomohiro Enokida, et al.. (2023). Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer. Frontiers in Oncology. 13. 1154771–1154771. 5 indexed citations
6.
Tajiri, Kazuko, Shinya Suzuki, Tomohiro Enokida, et al.. (2023). Association between baseline blood pressure and the incidence of lenvatinib‐induced hypertension in patients with thyroid cancer. Cancer Medicine. 12(22). 20773–20782. 4 indexed citations
7.
8.
Sato, Fumiaki, Atsunobu Sagara, Yukio Ando, et al.. (2022). COL8A1 facilitates the growth of triple-negative breast cancer via FAK/Src activation. Breast Cancer Research and Treatment. 194(2). 243–256. 15 indexed citations
9.
Sagara, Atsunobu, et al.. (2022). COL8A1 enhances the invasion/metastasis in MDA-MB-231 cells via the induction of IL1B and MMP1 expression. Biochemical and Biophysical Research Communications. 642. 145–153. 10 indexed citations
10.
Abe, Tomoya, et al.. (2021). Impact of air temperature and drug concentration on liquid emission from elastomeric pumps. Journal of Pharmaceutical Health Care and Sciences. 7(1). 1–1. 6 indexed citations
11.
Abe, Tomoya, et al.. (2020). Effect of different shielding conditions on the stability of Cisplatin. Journal of Pharmaceutical Health Care and Sciences. 6(1). 3–3. 3 indexed citations
12.
Koinuma, Masayoshi, et al.. (2020). Relationship between Low Pretreatment Geriatric Nutritional Risk Index and Poor Tolerability of Azacitidine in Patients with Myelodysplastic Syndromes. Annals of Nutrition and Metabolism. 76(6). 405–412. 3 indexed citations
13.
14.
Sagara, Atsunobu, Katsuhide Igarashi, Michiko Narita, et al.. (2016). Endocan as a prognostic biomarker of triple-negative breast cancer. Breast Cancer Research and Treatment. 161(2). 269–278. 35 indexed citations
15.
Sagara, Atsunobu, Katsuhide Igarashi, Noriko Gotoh, et al.. (2016). Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR. PLoS ONE. 11(10). e0164250–e0164250. 11 indexed citations
16.
Sakai, Hiroyasu, Atsunobu Sagara, Ara Jo, et al.. (2014). Mechanisms of cisplatin-induced muscle atrophy. Toxicology and Applied Pharmacology. 278(2). 190–199. 72 indexed citations
17.
Sakai, Hiroyasu, Atsunobu Sagara, Kenjiro Matsumoto, et al.. (2014). Neutrophil recruitment is critical for 5-fluorouracil-induced diarrhea and the decrease in aquaporins in the colon. Pharmacological Research. 87. 71–79. 45 indexed citations
18.
Sakai, Hiroyasu, Ken Sato, Satoshi Hasegawa, et al.. (2014). Distribution of aquaporin genes and selection of individual reference genes for quantitative real-time RT-PCR analysis in multiple tissues of the mouse. Canadian Journal of Physiology and Pharmacology. 92(9). 789–796. 16 indexed citations
19.
Sakai, Hiroyasu, Atsunobu Sagara, Kenjiro Matsumoto, et al.. (2013). 5-Fluorouracil Induces Diarrhea with Changes in the Expression of Inflammatory Cytokines and Aquaporins in Mouse Intestines. PLoS ONE. 8(1). e54788–e54788. 64 indexed citations
20.
Matsumoto, Kenjiro, Hiroyasu Sakai, Atsunobu Sagara, et al.. (2013). Increased Expression of 5-HT3 and NK1 Receptors in 5-Fluorouracil-Induced Mucositis in Mouse Jejunum. Digestive Diseases and Sciences. 58(12). 3440–3451. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yang Zheng Breakdown of academic impact, for papers by Lijun Yang Breakdown of academic impact, for papers by Fengming Zhu Breakdown of academic impact, for papers by Luca Pacini Breakdown of academic impact, for papers by Benling Qi Breakdown of academic impact, for papers by Xueran Kang Breakdown of academic impact, for papers by Krishna C. Penumatsa
Rankless by CCL
2026